FHTX Long Put Strategy
FHTX (Foghorn Therapeutics Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia and myelodysplastic syndrome; and FHD-609, a small molecule protein degrader for BRD9 to treat patients with synovial sarcoma. The company is also developing an enzymatic inhibitor and a protein degrader as selective modulators of BRM; and ARID1B selective modulators for the treatment of ovarian, endometrial, colorectal, bladder, and gastric cancers. It has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel oncology therapeutics against a transcription factor target; and with Loxo Oncology to create novel oncology medicines. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
FHTX (Foghorn Therapeutics Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $244.8M, a beta of 2.97 versus the broader market, a 52-week range of 3.27-6.95, average daily share volume of 148K, a public-listing history dating back to 2020, approximately 112 full-time employees. These structural characteristics shape how FHTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.97 indicates FHTX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long put on FHTX?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current FHTX snapshot
As of May 15, 2026, spot at $3.83, ATM IV 22.10%, IV rank 0.97%, expected move 6.34%. The long put on FHTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long put structure on FHTX specifically: FHTX IV at 22.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a FHTX long put, with a market-implied 1-standard-deviation move of approximately 6.34% (roughly $0.24 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated FHTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on FHTX should anchor to the underlying notional of $3.83 per share and to the trader's directional view on FHTX stock.
FHTX long put setup
The FHTX long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With FHTX near $3.83, the first option leg uses a $3.83 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed FHTX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 FHTX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $3.83 | N/A |
FHTX long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
FHTX long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on FHTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on FHTX
Long puts on FHTX hedge an existing long FHTX stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying FHTX exposure being hedged.
FHTX thesis for this long put
The market-implied 1-standard-deviation range for FHTX extends from approximately $3.59 on the downside to $4.07 on the upside. A FHTX long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long FHTX position with one put per 100 shares held. Current FHTX IV rank near 0.97% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on FHTX at 22.10%. As a Healthcare name, FHTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to FHTX-specific events.
FHTX long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. FHTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move FHTX alongside the broader basket even when FHTX-specific fundamentals are unchanged. Long-premium structures like a long put on FHTX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current FHTX chain quotes before placing a trade.
Frequently asked questions
- What is a long put on FHTX?
- A long put on FHTX is the long put strategy applied to FHTX (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With FHTX stock trading near $3.83, the strikes shown on this page are snapped to the nearest listed FHTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are FHTX long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the FHTX long put priced from the end-of-day chain at a 30-day expiry (ATM IV 22.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a FHTX long put?
- The breakeven for the FHTX long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current FHTX market-implied 1-standard-deviation expected move is approximately 6.34%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on FHTX?
- Long puts on FHTX hedge an existing long FHTX stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying FHTX exposure being hedged.
- How does current FHTX implied volatility affect this long put?
- FHTX ATM IV is at 22.10% with IV rank near 0.97%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.